Merck opens manufacturing facility in North Carolina
Merck Opens Vaccine Manufacturing Facility in North Carolina
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. Drugmakers have been exploring the possibility of government-granted exemptions for domestically manufactured medicines since Trump has threatened to impose 25% tariff on pharmaceutical imports.
According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...
Hosted on MSN19d
Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to AnalystsTim Hunt, CEO of the Alliance for Regenerative Medicine (ARM), emphasized increased funding in ... A close-up of a person's hand holding a bottle of pharmaceuticals. Merck & Co., Inc. (NYSE:MRK) ...
Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...
According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback